Rafferty Asset Management
CAPR icon

Rafferty Asset Management’s Capricor Therapeutics CAPR Stock Holding History

Rafferty Asset Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
60,373
-1,980
-3% -$60K ﹤0.01% 713
2026
Q1 		$1.9M Buy
+62,353
New +$1.66M 0.01% 623
2025
Q3 		– Sell
-47,946
Closed -$476K – 1112
2025
Q2 		$476K Sell
47,946
-35,042
-42% -$370K ﹤0.01% 900
2025
Q1 		$788K Sell
82,988
-43,323
-34% -$601K ﹤0.01% 789
2024
Q4 		$1.74M Buy
+126,311
New +$2.21M 0.01% 683

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Rafferty Asset Management's CAPR Position: Q2 2026 in Review

Rafferty Asset Management reduced its Capricor Therapeutics (CAPR) stake by 3.2% in Q2 2026, selling an estimated $60K and leaving 60,373 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Rafferty Asset Management first reported a position in CAPR in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.9M in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Rafferty Asset Management held 60,373 shares of Capricor Therapeutics worth $1.45M as of Q2 2026.
  • Rafferty Asset Management sold 1,980 Capricor Therapeutics shares in Q2 2026, an estimated $60K.
  • Capricor Therapeutics made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #713 holding.
  • Rafferty Asset Management first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Rafferty Asset Management's Capricor Therapeutics position peaked at $1.9M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.